Cargando…
Post-COVID lung fibrosis: The tsunami that will follow the earthquake
The SARS-CoV-2 pandemic has already infected in excess of 50 million people worldwide and resulted in 1.2 million deaths. While the majority of those infected will not have long-term pulmonary sequelae, 5%–10% will develop severe COVID-19 pneumonia and acute respiratory distress syndrome (ARDS). The...
Autores principales: | Udwadia, Zarir F, Koul, Parvaiz A, Richeldi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104338/ https://www.ncbi.nlm.nih.gov/pubmed/33686978 http://dx.doi.org/10.4103/lungindia.lungindia_818_20 |
Ejemplares similares
-
The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021) -
Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
por: Udwadia, Zarir F., et al.
Publicado: (2015) -
Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
por: Richeldi, Luca, et al.
Publicado: (2015) -
Correction to: Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
por: Richeldi, Luca, et al.
Publicado: (2021) -
Oxaliplatin-induced lung fibrosis
por: Shah, Arpan, et al.
Publicado: (2009)